Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Review ArticleReviewsR

Contribution of Computed Tomographic Angiography to Pretreatment Planning of Radio-embolization of Liver Tumors

HYNEK MIRKA, PETR DURAS, JAN BAXA, EVA KORCAKOVA and JIRI FERDA
Anticancer Research July 2018, 38 (7) 3825-3829; DOI: https://doi.org/10.21873/anticanres.12666
HYNEK MIRKA
1Department of Imaging Methods, Faculty of Medicine in Pilsen, Charles University in Prague and Teaching Hospital, Pilsen, Czech Republic
2Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mirka{at}fnplzen.cz
PETR DURAS
1Department of Imaging Methods, Faculty of Medicine in Pilsen, Charles University in Prague and Teaching Hospital, Pilsen, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JAN BAXA
1Department of Imaging Methods, Faculty of Medicine in Pilsen, Charles University in Prague and Teaching Hospital, Pilsen, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EVA KORCAKOVA
1Department of Imaging Methods, Faculty of Medicine in Pilsen, Charles University in Prague and Teaching Hospital, Pilsen, Czech Republic
2Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JIRI FERDA
1Department of Imaging Methods, Faculty of Medicine in Pilsen, Charles University in Prague and Teaching Hospital, Pilsen, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Transarterial radio-embolization (TARE) using yttrium-90 microspheres is a promising method based on the brachytherapeutic effect of radionuclide with beta-minus decay dissolved in solid microparticles applied directly to tumor-supplying arteries. This treatment is complex, as well as logistically and technically extremely demanding and must be planned in detail. The visualization of the vascular supply of the liver and the possible parasitic supply of the tumor is essential not only for indication of the procedure and correct identification of the arteries to which the microspheres will be applied, but also for prevention of non-target deposition of radioactive material. This review addresses the use of computed tomographic angiography in the preparatory phase of TARE.

  • Radio-embolization
  • yttrium-90
  • liver tumor
  • computed tomography
  • angiography
  • review

Locoregional treatment is currently an important part of comprehensive care for patients with liver tumors. Specifically, it is indicated in patients with primary and secondary malignancies who are not suitable candidates for liver resection or transplantation. Standard methods used in this area are thermal ablation (radiofrequency ablation, microwave ablation or cryo-ablation) and intra-arterial treatment (TACE) (1). Transarterial radio-embolization (TARE) using yttrium-90-containing glass or resin microspheres is a promising new method based on the brachytherapeutic effect of radionuclide particles applied directly to the tumor-supplying arteries (2). This treatment is complex, as well as logistically and technically extremely demanding, and must be planned in detail. Therefore, the anatomical and functional parameters of the liver and its circulation are assessed in a multimodal manner using radiological and nuclear medicine methods. The visualization of the vascular supply of the liver and the possible parasitic supply of the tumor is essential, not only for indication of the procedure and correct identification of the arteries to which the microparticles will be applied, but also for prevention of non-target deposition of radioactive material (3). This review addresses the use of imaging methods in mapping of the liver arterial anatomy in the preparatory phase of TARE.

Arterial Supply of the Liver and its Importance in TARE

The complex embryonal development of the hepatobiliary system predisposes this area to having a highly variable arterial anatomy (4). A classic arrangement with two hepatic arteries arising from the proper hepatic artery, which is a branch of the common hepatic artery arising from the truncus coeliacus, occurs in 50-61% of individuals (5-7). In other cases, the arteries are replaced, or accessory arteries are found (Figure 1). According to Michels' classification, 10 types of arterial variants exist (Table I) (8). The arteries that supply the surrounding organs can also originate from hepatic arteries. For example, the right gastric artery, accessory left hepatic artery, lower diaphragmatic artery and umbilical artery may be branches of the left hepatic artery (9). An examination of liver segment IV should be focused on the possible presence of the middle hepatic artery, which may be a branch of the right hepatic artery or arise directly from the proper hepatic artery as a trifurcation with the end branches of the right or left hepatic artery passing on the other side. Moreover, mapping the distance of normal arterial branches from the point of microsphere application is also important, especially for the gastroduodenal and cystic arteries (10). Specifically, up to 17% of tumors located on the liver surface have a parasitic arterial supply (Table II) (11).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Anatomic variants of hepatic arteries (8).

Non-target radiopharmaceutical deposition may cause serious complications, such as cholecystitis, gastrointestinal ulceration or bleeding, gastritis, duodenitis, pancreatitis, hepatitis, supra-umbilical dermatitis and radiation pneumonitis (12-14). Therefore, all patients undergo protective embolization of the gastroduodenal artery, left gastric artery, cystic artery or other arteries which may allow the non-target deposition of microspheres (15, 16). To ensure the redistribution of blood in the liver, individual branches supplying liver tissue may be embolized in some patients. Other adverse factors that increase the probability of embolization in non-target areas are stenoses and the slowing of flow in the hepatic arteries. Proper catheter positioning based on the knowledge of the liver arterial architecture is essential in order to perform the evaluation of liver perfusion and assessment of hepatopulmonary fraction deposition of microspheres before TARE. Hepatopulmonary shunting is evaluated with single photon-emission computed tomography/computed tomography (SPECT/CT) using technetium-99 m-labelled human albumin macro-aggregate in order to assess the potential radiation injury, occurring when the arteriovenous shunting exceeds more than one-tenth of the applied activity.

Imaging of portal venous system is also very important in the planning of TARE. Portal vein thrombosis with the absence of hepatopetal flow increases the likelihood of ischemic involvement of the liver and is a contraindication for TARE using resin microspheres. The procedure with glass micro-spheres can be successfully performed in this condition (17).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Extrahepatic collaterals supplying liver tumors (9).

Methods of Liver Artery Imaging

Based on the above, the Imaging of liver artery variants and the parasitic supply is necessary in order to optimize the effect of TARE. To this end, the gold standard method is digital subtraction angiography (DSA). DSA consists of the non-selective imaging of the abdominal aorta, the selective imaging of the coeliac axis and superior mesenteric artery, and the super-selective imaging of all arteries that supply the hepatic parenchyma. In addition to the right and left hepatic arteries, the cystic artery, supraduodenal, retroduodenal, falciform, left gastric accessory, and right and left inferior phrenic arteries should also be located. Angiography may be supplemented with cone-beam CT which, contrary to multi-detector CT, uses a two-dimensional detector. From the data obtained, three-dimensional images showing not only the anatomy of the arteries but also the tumor tissue can be reconstructed. Cone-beam CT use in hepatic interventional radiology thus enables more selective catheterization and increased treatment efficacy. The diagnostic part of the procedure may be followed by protective embolization using metallic spirals or tissue glue of arteries that might allow the non-target deposition of microspheres.

Moreover, CT or positron-emission tomography (PET)/CT images of the liver including a series of thin slices in the arterial and venous phase are a common part of liver tumor staging. Specifically, performing the CT scan on a multi-detector scanner (optimally with 64 or more detector rows) allows a fairly detailed assessment of vascularity, but hepatic artery imaging can also be performed using magnetic resonance imaging (MRI) (18).

Technique of CT Angiography (CTA)

CT images of the liver are obtained after the injection of contrast medium (CM) in the arterial, venous and, optionally, equilibrium phases. The volume of CM should correspond to 500-600 mgI per kilogram of body weight, and the iodine flux should be in the range of 1.6-2.0 g/s. CM injection is followed by a saline flush to ensure high-quality visualization of both the arterial and venous system, the liver parenchyma, and possible focal lesions (19). In order to increase the contrast between the vessels and structures of the gastrointestinal tract, the per-oral application of water or mannitol water solution is advisable. Moreover, if the examination is performed only to map the liver artery, the volume of CM can be reduced by approximately 20% (20).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Computed tomography angiography (CTA) of the liver showing the intrahepatic segmentation of the hepatic artery. A trifurcation of the hepatic artery (arrow) is visible. The supplementary artery supplies the gall bladder and part of the metastasis. A: CTA, volume-rendered 3D reconstruction. B: CTA, maximum intensity projection of hepatic arteries. C: Catheter-based perfusion image from cone-beam CT. D: Axial CT image of liver metastasis before transarterial radio-embolisation (TARE). E: Axial CT image 6 weeks after TARE. F: Axial CT image 6 months after TARE, with visible size reduction and decrease in density representing necrosis.

The early arterial phase (15-20 s after the start of CM injection or immediately after reaching a threshold of 100 HU in the aorta) is recommended for arterial imaging. At this stage, the concentration of CM is sufficient in the arteries but not in the portal vein and hypervascular lesions, which are not yet enhanced. Therefore, the signal-to-noise ratio is higher between the vessels and surrounding structures, which simplifies the visualization of small arteries. However, liver tumors should be imaged in the late arterial phase (approximately 35-40 s after the start of the contrast medium injection or 15-20 s after reaching a threshold of 100 HU in the aorta). At this phase, the portal vein and hypervascular liver lesions are enhanced, which results in a lower signal-to-noise ratio. However, in a study to compare the benefits of early and late arterial phase examinations of liver arterial variants, Van den Hoven et al. showed that liver arterial imaging did not produce significantly worse results in the late arterial phase than the early arterial phase (21).

In non-obese patients, the low-voltage (80-100 kV) technique is preferred in because it increases the CM contrast and consequently increases the resolution of blood vessels and hypervascular focal lesions at a lower radiation dose (22). Depending on the voltage drop, the current must be increased to optimize image quality, and the ratio of contrast to noise is not significantly reduced under these conditions (23). To optimize the exposure parameters, automatic kVp setting and automatic off-line and on-line current modulation systems are currently used. Alternatively, image noise and radiation load can also be reduced using iterative reconstructions.

Scanning on multi-detector devices is performed using submillimetric collimation (typically 0.5-0.75 mm), which ensures an isotropic data field that allows multiplanar reformations and three-dimensional reconstructions in any plane without a loss of resolution. To increase spatial resolution, some authors recommend the use of the edge-enhancement reconstruction algorithm (24). Thin axial sections and multiplanar reformations or maximum intensity projection reconstructions are used for evaluation (25).

The Importance of CTA

CTA provides sufficient time and spatial resolution for replacing diagnostic angiography in clinical practice. Optimally performed examinations can detect arterial branches with a diameter of 1 mm, and visualizing the hepatic arteries with proximal widths between 2-3 mm is usually sufficient (26, 27). Comparative studies of the accuracy of CTA and other methods (DSA, cone-beam CT) indicate that DSA is more accurate when detecting liver arterial anomalies, especially in the area of the right hepatic artery (detectable at 65% CTA). However, the authors of these studies also agree that CTA accurately assesses the supply of the fourth hepatic segment (up to 36% higher detecability than with DSA) (21, 28, 29). Similarly, good results were obtained in the detection of the falciform artery – Burgman et al. detected this artery in 4.5 as many patients when using CTA compared with DSA (52.3 vs. 11.9%) (29). MRI, alone or as a part of PET/MRI, is another commonly used method for detection, differential diagnosis and staging of liver tumors. As with CT, liver artery anatomy can be evaluated in images obtained in the arterial phase. However, this method is less accurate than CTA; one study showed that the reliability of MRI was lower than that of CTA, especially in the area of the left hepatic artery (18).

Despite the limitations associated with CTA, it can be considered a suitable method for planning the catheterization procedure. Specifically, it accelerates and consequently reduces the radiation load and the amount of CM required, which is beneficial, especially for patients with impaired renal function (10, 21, 28).

Acknowledgements

This article was supported by the project of the Ministry of Health-Conceptual Development of Research Institutions 00669806 – FN Plzen, by the project of the Charles University Prague Progress Q39 and by the project CZ.1.05/2.1.00/03.0076 from the European Regional Development Fund.

Footnotes

  • This article is freely accessible online.

  • Received April 19, 2018.
  • Revision received May 14, 2018.
  • Accepted May 16, 2018.
  • Copyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

References

  1. ↵
    1. Lencioni R
    : Loco-regional treatment of hepatocellular carcinoma. Hepatology 52: 762-773, 2010.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Sacco R,
    2. Mismas V,
    3. Marceglia S,
    4. Romano A,
    5. Giacomelli L,
    6. Bertini M,
    7. Federici G,
    8. Metrangolo S,
    9. Parisi G,
    10. Tumino E,
    11. Bresci G,
    12. Corti A,
    13. Tredici M,
    14. Piccinno M,
    15. Giorgi L,
    16. Bartolozzi C,
    17. Bargellini I
    : Transarterial radioembolization for hepatocellular carcinoma: An update and perspectives. World J Gastroenterol 21: 6518-6525, 2015.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Riaz A,
    2. Awais R,
    3. Salem R
    : Side-effects of yttrium-90 radioembolization. Front Oncol 4: 198, 2014.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Liu DM,
    2. Salem R,
    3. Bui JT,
    4. Courtney A,
    5. Barakat O,
    6. Sergie Z,
    7. Atassi B,
    8. Barrett K,
    9. Gowland P,
    10. Oman B,
    11. Lewandowski RJ,
    12. Gates VL,
    13. Thurston KG,
    14. Wong CY
    : Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol 16: 911-935, 2005.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Lee AJ,
    2. Gomes AS,
    3. Liu DM,
    4. Kee ST,
    5. Loh CT,
    6. McWilliams JP
    : The road less traveled: importance of the lesser branches of the celiac axis in liver embolotherapy. Radiographics 32: 1121-1132, 2012.
    OpenUrlCrossRefPubMed
    1. Ugurel MS,
    2. Battal B,
    3. Bozlar U,
    4. Nural MS,
    5. Tasar M,
    6. Ors F,
    7. Saglam M,
    8. Karademir I
    : Anatomical variations of hepatic arterial system, coeliac trunk and renal arteries: an analysis with multidetector CT angiography. Br J Radiol 83: 661-667, 2010.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Covey AM,
    2. Brody LA,
    3. Maluccio MA,
    4. Getrajdman GI,
    5. Brown KT
    : Variant hepatic arterial anatomy revisited: Digital subtraction angiography performed in 600 patients. Radiology 224: 542-547, 2002.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Michels NA
    : Newer anatomy of the liver and its variant blood supply and collateral circulation. Am J Surg 112: 337-347, 1966.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Song SY,
    2. Chung JW,
    3. Lim HG,
    4. Park JH
    : Nonhepatic arteries originating from the hepatic arteries: Angiographic analysis in 250 patients. J Vasc Interv Radiol 17: 461-469, 2006.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Camacho JC,
    2. Moncayo V,
    3. Kokabi N,
    4. Reavey HE,
    5. Galt JR,
    6. Yamada K,
    7. Kies DD,
    8. Williams RS,
    9. Kim HS,
    10. Schuster DM
    : (90)Y Radioembolization: Multimodality imaging pattern approach with angiographic correlation for optimized target therapy delivery. Radiographics 35: 1602-1618, 2015.
    OpenUrlPubMed
  10. ↵
    1. Lee EW,
    2. Thakor AS,
    3. Tafti BA,
    4. Liu DM
    : Y90 selective internal radiation therapy. Surg Oncol Clin N Am 24: 167-185, 2015.
    OpenUrlPubMed
  11. ↵
    1. Salem R,
    2. Thurston KG,
    3. Covey AM,
    4. Brody LA,
    5. Maluccio MA,
    6. Getrajdman GI,
    7. Brown KT
    : Radioembolization with 90yttrium microspheres: A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. J Vasc Interv Radiol 17: 1251-1278, 2006.
    OpenUrlCrossRefPubMed
    1. Murthy R,
    2. Nunez R,
    3. Szklaruk J,
    4. Erwin W,
    5. Madoff DC,
    6. Gupta S,
    7. Ahrar K,
    8. Wallace MJ,
    9. Cohen A,
    10. Coldwell DM,
    11. Kennedy AS,
    12. Hicks ME
    : Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics 25(Suppl 1): S41-S55, 2005.
    OpenUrlPubMed
  12. ↵
    1. Vente MA,
    2. Wondergem M,
    3. van der Tweel I,
    4. van den Bosch MA,
    5. Zonnenberg BA,
    6. Lam MG,
    7. van Het Schip AD,
    8. Nijsen JF
    : Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis. Eur Radiol 19: 951-959, 2009.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Hamoui N,
    2. Minocha J,
    3. Memon K,
    4. Sato K,
    5. Ryu R,
    6. Salem R,
    7. Lewandowski RJ
    : Prophylactic embolization of the gastroduodenal and right gastric arteries is not routinely necessary before radioembolization with glass microspheres. J Vasc Interv Radiol 24: 1743-1745, 2013.
    OpenUrlCrossRefPubMed
  14. ↵
    1. McWilliams JP,
    2. Kee ST,
    3. Loh CT,
    4. Lee EW,
    5. Liu DM
    : Prophylactic embolization of the cystic artery before radioembolization: Feasibility, safety, and outcomes. Cardiovasc Intervent Radiol 34: 786-792, 2011.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Salem R,
    2. Lewandowski R,
    3. Roberts C,
    4. Goin J,
    5. Thurston K,
    6. Abouljoud M,
    7. Courtney A
    : Use of yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol 15: 335-345, 2004.
    OpenUrlPubMed
  16. ↵
    1. Lee MW,
    2. Lee JM,
    3. Lee JY,
    4. Kim SH,
    5. Park EA,
    6. Han JK,
    7. Kim YJ,
    8. Shin KS,
    9. Suh KS,
    10. Choi BI
    : Preoperative evaluation of the hepatic vascular anatomy in living liver donors: Comparison of CT angiography and MR angiography. J Magn Reson Imaging 24: 1081-1087, 2006.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Laghi A
    : MDCT Protocols Whole Body and Emergencies. Milan, Springer-Verlag, pp. 96-111, 2012.
  18. ↵
    1. Saba L
    : CT Imaging of Hepatic Arteries. In: Computed Tomography-Clinical Applications. InTech Open, pp. 231-240, 2012.
  19. ↵
    1. Van den Hoven AF,
    2. Braat MN2,
    3. Prince JF,
    4. van Doormaal PJ,
    5. van Leeuwen MS,
    6. Lam MG,
    7. van den Bosch MA
    : Liver CT for vascular mapping during radioembolisation workup: comparison of an early and late arterial phase protocol. Eur Radiol 27: 61-69, 2017.
    OpenUrlPubMed
  20. ↵
    1. Tang K,
    2. Wang L,
    3. Li R,
    4. Lin J,
    5. Zheng X,
    6. Cao G
    : Effect of low tube voltage on image quality, radiation dose, and low-contrast detectability at abdominal multidetector CT: Phantom study. J Biomed Biotechnol 2012: 130169, 2012.
    OpenUrlPubMed
  21. ↵
    1. Quaia E
    : Comparison between 80 kV, 100 kV and 120 kV CT protocols in the assessment of the therapeutic outcome in HCC. Liver Pancreat Sci 1: 1-4, 2016.
    OpenUrl
  22. ↵
    1. Ng EH,
    2. Chung JB,
    3. Klass D,
    4. Ho SG,
    5. Patel R,
    6. Chou FY,
    7. Legiehn GM,
    8. Liu DM
    : Optimized computed tomographic angiography vessel evaluation protocol (OCTAVE) prior to trans arterial radioembolization. Intervent Oncol 360(4): E183-E193, 2016.
    OpenUrl
  23. ↵
    1. Price M,
    2. Patino M,
    3. Sahani D
    : Computed tomography angiography of the hepatic, pancreatic, and splenic circulation. Radiol Clin North Am 54: 55-70, 2016.
    OpenUrlPubMed
  24. ↵
    1. Kumamaru KK,
    2. Hoppel BE,
    3. Mather RT,
    4. Rybicki FJ
    : CT Angiography: Current technology and clinical use. Radiol Clin North Am 48: 213-235, 2010.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Silveira LA,
    2. Silveira FBC,
    3. Fazan VPS
    : Arterial diameter of the celiac trunk and its branches. Anatomical study. Acta Cirúrg Bras 24: 44-47, 2009.
    OpenUrl
  26. ↵
    1. Irfan A,
    2. Weir G
    : Hepatic arterial mapping by CT angiography, cone beam CT and digital subtraction angiography. J Liver Res Disord Ther 2: 00020, 2016.
    OpenUrl
  27. ↵
    1. Burgmans MC,
    2. Too CW,
    3. Kao YH,
    4. Goh AS,
    5. Chow PK,
    6. Tan BS,
    7. Tay KH,
    8. Lo RH
    : Computed tomography hepatic arteriography has a hepatic falciform artery detection rate that is much higher than that of digital subtraction angiography and 99mTc-MAA SPECT/CT: Implications for planning 90Y radioembolization? Eur J Radiol 81: 3979-3984, 2012.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 38, Issue 7
July 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Contribution of Computed Tomographic Angiography to Pretreatment Planning of Radio-embolization of Liver Tumors
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Contribution of Computed Tomographic Angiography to Pretreatment Planning of Radio-embolization of Liver Tumors
HYNEK MIRKA, PETR DURAS, JAN BAXA, EVA KORCAKOVA, JIRI FERDA
Anticancer Research Jul 2018, 38 (7) 3825-3829; DOI: 10.21873/anticanres.12666

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Contribution of Computed Tomographic Angiography to Pretreatment Planning of Radio-embolization of Liver Tumors
HYNEK MIRKA, PETR DURAS, JAN BAXA, EVA KORCAKOVA, JIRI FERDA
Anticancer Research Jul 2018, 38 (7) 3825-3829; DOI: 10.21873/anticanres.12666
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Arterial Supply of the Liver and its Importance in TARE
    • Methods of Liver Artery Imaging
    • Technique of CT Angiography (CTA)
    • The Importance of CTA
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Liver Radioembolization: Predicting Lung Shunt Fraction with Contrast-Enhanced CT, Eliminating the Need for 99mTc-MAA
  • Google Scholar

More in this TOC Section

  • Cytokine-based Cancer Immunotherapy: Challenges and Opportunities for IL-10
  • Proteolytic Enzyme Therapy in Complementary Oncology: A Systematic Review
  • Multimodal Treatment of Primary Advanced Ovarian Cancer
Show more Reviews

Keywords

  • Radio-embolization
  • yttrium-90
  • liver tumor
  • computed tomography
  • angiography
  • review
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire